Literature DB >> 12507298

Murine embryonic stem cell in vitro differentiation: applications to the study of vascular development.

O Feraud1, D Vittet.   

Abstract

The present review summarizes knowledge accumulated during the last decade concerning in vitro endothelial differentiation from embryonic stem (ES) cells. There is now growing evidence that ES cells may provide a powerful model system to determine the cellular and molecular mechanisms of vascular development. ES cells differentiate into the endothelial lineage by successive maturation steps recapitulating in vivo events observed in the embryo. Further maturation of ES-derived embryoid bodies either in three dimensional gels or in confrontation cultures with tumor spheroids can also provide a model of physiological or tumoral angiogenesis. The data obtained from experimental in vitro differentiation of genetically modified mouse ES cells highlight the potential and the complementarity of this model system to in vivo gene knock out studies. We also consider and discuss some of the potential applications of ES cell technology in vascular biology for future directions in basic research and medicine, by manipulation of differentiation and the generation of cell populations for analysis and transplantation for therapeutic use.

Entities:  

Mesh:

Year:  2003        PMID: 12507298     DOI: 10.14670/HH-18.191

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.

Authors:  Agnès Desroches-Castan; Delphine Quélard; Martine Demeunynck; Jean-François Constant; Chongling Dong; Michelle Keramidas; Jean-Luc Coll; Caroline Barette; Laurence Lafanechère; Jean-Jacques Feige
Journal:  Oncotarget       Date:  2015-03-10

2.  ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.

Authors:  Zhen Liu; Franck Lebrin; Janita A Maring; Sander van den Driesche; Stieneke van der Brink; Maarten van Dinther; Midory Thorikay; Sabrina Martin; Kazuki Kobayashi; Lukas J A C Hawinkels; Laurens A van Meeteren; Evangelia Pardali; Jeroen Korving; Michelle Letarte; Helen M Arthur; Charles Theuer; Marie-José Goumans; Christine Mummery; Peter ten Dijke
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.